Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients

被引:61
作者
Tirumani, Sree Harsha [1 ,2 ]
Deaver, Pamela [2 ]
Shinagare, Atul B. [1 ,2 ]
Tirumani, Harika [1 ]
Hornick, Jason L. [3 ]
George, Suzanne [4 ,5 ]
Ramaiya, Nikhil H. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA
[4] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Sarcoma & Bone Oncol, Boston, MA 02215 USA
[5] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA
关键词
Leiomyosarcoma; Neoplasm recurrence; Prognosis; Proportional Hazards Models; SURVIVAL; UTERUS;
D O I
10.3802/jgo.2014.25.4.306
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To describe metastatic pattern of uterine leiomyosarcomas (ULMS) and correlate it with clinical and histopathologic parameters. Methods: we included 113 women (mean age, 53 years; range, 29 to 72 years) with histopathology-confirmed ULMS from 2000 to 2012. Distribution of metastases was noted from imaging by two radiologists in consensus. Predictors of development of metastases were analyzed with univariate and multivariate analysis. Impact of various clinical and histopathologic parameters on survival was compared using Log-rank test and Cox proportional hazard regression model. Results: Distant metastases were seen in 81.4% (92/113) of the patients after median interval of 7 months (interquartile range, 1 to 21). Lung was most common site of metastases (74%) followed by peritoneum (41%), bones (33%), and liver (27%). Local tumor recurrence was noted in 57 patients (50%), 51 of whom had distant metastases. Statistically significant correlation was noted between local recurrence and peritoneal metastases (p<0.001) and between lung and other common sites of hematogeneous metastases (p<0.05). Age, serosal involvement, local recurrence, and the International Federation of Gynecology and Obstetrics (FIGO) stage were predictive factors for metastases. At the time of reporting, 65% (74/113) of the patients have died; median survival was 45 months. Stage, local recurrence, and age were poor prognostic factors. Conclusion: ULMS metastasizes most frequently to lung, peritoneum, bone, and liver. Local recurrence was associated with peritoneal spread and lung metastases with other sites of hematogeneous metastases. Age, FIGO stage and local recurrence predicted metastatic disease and advanced stage, older age and local recurrence predicted poor outcome.
引用
收藏
页码:306 / 312
页数:7
相关论文
共 24 条
  • [1] Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients
    Abeler, Vera M.
    Royne, Odd
    Thoresen, Steinar
    Danielsen, Havard E.
    Nesland, Jahn M.
    Kristensen, Gunnar B.
    [J]. HISTOPATHOLOGY, 2009, 54 (03) : 355 - 364
  • [2] Uterine leiomyosarcoma metastasis to the pancreas: Report of a case and review of the literature
    Alonso Gómez J.
    Arjona Sánchez Á.
    Martínez Cecilia D.
    Díaz Nieto R.
    Roldán De La Rúa J.
    Valverde Martínez A.
    Lizárraga Febres E.
    Padillo Ruiz J.
    Rufián Peña S.
    [J]. Journal of Gastrointestinal Cancer, 2012, 43 (2) : 361 - 363
  • [3] [Anonymous], NCCN CLIN PRACT GUID
  • [4] Metastatic Uterine Leiomyosarcomas A Single-Institution Experience
    Bernstein-Molho, Rinat
    Grisaro, Dan
    Soyfer, Vjacheslav
    Safra, Tamar
    Merimsky, Ofer
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (02) : 255 - 260
  • [5] Extensive Cardiac Metastases Secondary to Uterine Leiomyosarcoma
    Calleja, Anna M.
    Wellnitz, Clinton V.
    Alharthi, Mohsen S.
    Khandheria, Bijoy K.
    Chaliki, Hari P.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2009, 22 (12) : 1419.e5 - 1419.e7
  • [6] Isolated cutaneous metastasis of uterine leiomyosarcoma: case report and review of literature
    Corcoran, Shane
    Hogan, Aisling M.
    Nemeth, Tamas
    Bennani, Fadel
    Sullivan, Francis J.
    Khan, Waqar
    Barry, Kevin
    [J]. DIAGNOSTIC PATHOLOGY, 2012, 7
  • [7] Cordioli E, 1999, Cardiologia, V44, P1001
  • [8] Erkal HS, 2008, TUBERK TORAK, V56, P92
  • [9] Uterine leiomyosarcoma: Analysis of treatment failures and survival
    Gadducci, A
    Landoni, F
    Sartori, E
    Zola, P
    Maggino, T
    Lissoni, A
    Bazzurini, L
    Arisio, R
    Romagnolo, C
    Cristofani, R
    [J]. GYNECOLOGIC ONCOLOGY, 1996, 62 (01) : 25 - 32
  • [10] Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy
    Giuntoli, RL
    Metzinger, DS
    DiMarco, CS
    Cha, SS
    Sloan, JA
    Keeney, GL
    Gostout, BS
    [J]. GYNECOLOGIC ONCOLOGY, 2003, 89 (03) : 460 - 469